Ghebreyesus
WHO seeks G7 support to meet vaccination targets
The Director-General, World Health Organisation (WHO), Dr Tedros Ghebreyesus has solicited the support of G7 health ministers to meet vaccination targets by the end of the year. In his remarks at the G7 Health Ministers’ meeting in Oxford, Ghebreyesus appealed to the ministers to provide leadership for strengthening WHO on sustainable financing. “First, we seek your support for reaching our vaccination targets for September and the end of the year; sharing doses with COVAX now is essential for achieving those targets. “We need 250 million doses by September and we need 100 million doses just in June and July. “As G7 nations, you are in a unique position to pool doses and make this happen; second, we seek your leadership for strengthening WHO, including through sustainable and predictable f...
Hydroxychloroquine Trials for COVID-19 Suspended by WHO
Sourced from Getty Images. The World Health Organization (WHO) announced that it is pausing clinical trials on the use of the controversial malaria drug, hydroxychloroquine, to treat patients with COVID-19. This was one of four experimental treatments being investigated by the organization and has been under intense scrutiny for some time after it was championed by tech mogul Elon Musk and US President Donald Trump. “The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” says Tedros Adhanom Ghebreyesus, WHO director-general, during a press briefing. This “Solidarity trial” is the WHO’s global investigation into experimental treatments for COVID-19 – including hyd...
